Pregabalin Capsule
Product Images NDC 71205-323

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71205-323-90 (Pregabalin Caps 100mg 90s Count)

71205-323-90 (Pregabalin Caps 100mg 90s Count)
This is a medication bottle of Pregabalin, a controlled substance used for treating epilepsy, anxiety and other nerve-related pain conditions. The bottle contains 90 capsules each having 100mg of pregabalin. The bottle is manufactured by ScieGen Pharmaceuticals Inc. and relabeled by Proficient Rx LP. Each capsule is a size 3 hard gelatin capsule with an orange opaque colored cap and body. The body of the capsule features the numbers '353' and the cap has 'SG' printed on it with black ink. The bottle shows a lot number of 00000 with an expiration date which has been obscured or worn out. The GTIN and SN# are 0371205323905 and SN# MASTER respectively. No evidence of any instructions or indications but a Medication Guide is to be provided to each patient.*
FDA Label Image

Figure 1 (Pregabalin Fig01)

Figure 1 (Pregabalin Fig01)
FDA Label Image

Figure 2 (Pregabalin Fig02)

Figure 2 (Pregabalin Fig02)
FDA Label Image

Figure 3 (Pregabalin Fig03)

Figure 3 (Pregabalin Fig03)
FDA Label Image

Figure 4 (Pregabalin Fig04)

Figure 4 (Pregabalin Fig04)
FDA Label Image

Figure 5 (Pregabalin Fig05)

Figure 5 (Pregabalin Fig05)
FDA Label Image

Figure 6 (Pregabalin Fig06)

Figure 6 (Pregabalin Fig06)
FDA Label Image

Figure 7 (Pregabalin Fig07)

Figure 7 (Pregabalin Fig07)
FDA Label Image

Figure 9 (Pregabalin Fig08)

Figure 9 (Pregabalin Fig08)
FDA Label Image

Figure 10 (Pregabalin Fig09)

Figure 10 (Pregabalin Fig09)
This appears to be a chart or graph with the estimated percentage of subjects without LTR (unknown abbreviation) listed on the left-hand side of the graph. The chart shows two lines labeled "Progabain" and "Placebo" along the X-axis which represents time in days. Without further context or information, it is difficult to determine the purpose or significance of this chart.*
FDA Label Image

Figure 11 (Pregabalin Fig10)

Figure 11 (Pregabalin Fig10)
FDA Label Image

Figure 12 (Pregabalin Fig11)

Figure 12 (Pregabalin Fig11)
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
This text provides a formula to calculate creatinine clearance (CLCT) in patients, using their age, weight, and serum creatinine levels. The formula varies slightly for female patients, who must multiply their result by 0.85.*
FDA Label Image

Chemical Structure (Pregabalin Str)

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.